Medical release archive
Here you can find the archive of all Medical releases prior to 2019
Filter by date:
Showing 42 medical releases before 2019
-
AstraZeneca enrols first patient in new Brilinta (ticagrelor) stroke trial
-
Risk of repeat heart attack twice as likely from occlusions in arteries that did not cause initial event
-
New England Journal of Medicine publishes results of Phase III FLAURA trial in the 1st-line treatment of EGFR-mutated non-small cell lung cancer
-
New data show benefit of Tagrisso in patients with EGFR-mutated non-small cell lung cancer and central nervous system metastases
-
Faslodex (fulvestrant) receives EU approval for the treatment of hormone receptor-positive advanced breast cancer in combination with palbociclib
-
ZS-9 (sodium zirconium cyclosilicate) Phase III long-term safety and efficacy data presented at ASN Kidney Week 2017
-
AstraZeneca and Chi-Med’s savolitinib shows encouraging clinical activity in EGFR mutation-positive lung cancer with MET-amplification
-
Forxiga DEPICT-1 trial demonstrates improved glycaemic control without increasing hypoglycaemia, lowered weight and total daily insulin dose in patients with type-1 diabetes
-
AstraZeneca presents new evidence on Symbicort (budesonide/formoterol) in COPD patients at risk of exacerbation
-
New data supports long-term efficacy of ticagrelor in patients up to five years following a heart attack
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Email the Global Media Relations team at:
Gonzalo Viña
Head of Global Media Relations
+44 (0)1223 344 800
Kim Blomley
Director Global Media Relations (Oncology)
+44 (0)1223 344 800
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Fiona Cookson
Director Global Media Relations (Covid-19)
+44 (0)1223 344 800
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106